z-logo
open-access-imgOpen Access
A Randomized Controlled Trial Comparing Zileuton With Theophylline in Moderate Asthma
Author(s) -
Howard J. Schwartz,
Thomas L. Petty,
Louise M. Dubé,
Linda J. Swanson,
John F. Lancaster
Publication year - 1998
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.158.2.141
Subject(s) - zileuton , medicine , theophylline , asthma , placebo , anesthesia , bronchodilator , spirometry , crossover study , randomized controlled trial , arachidonic acid , arachidonate 5 lipoxygenase , chemistry , biochemistry , alternative medicine , pathology , enzyme
Zileuton, a leukotriene pathway inhibitor, was compared with slowly absorbed theophylline in a randomized, double-blind study of patients with chronic asthma. The primary efficacy measure was improvement in forced expiratory volume in 1 second (FEV1).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom